NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2024
Back to search
Official data from USPTO
OPSIS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OPSIS THERAPEUTICS
ST13
US500000090027853Class
5, 10
Filing
90027853
Registration
7434279
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
07/02/2024
Trademark type
Word
Nice classes
5, 10
Filing date
06/30/2020
Registration date
07/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/02/2024
Last transaction
07/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/04/2024
First use in commerce
05/04/2024
Drawing code
4
Owner type
16
Owner location
Madison, WI
Examiner
FOSDICK, GEOFFREY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Opsis Therapeutics, LLC
Representatives
Jason M. Hunt BOARDMAN & CLARK LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations derived from human stem cells for the treatment of ocular disorders; living tissue grafts for surgical implantation for the treatment of ocular disorders
Class 10
Implants comprising naturalnon-living materials derived from human stem cells useful for treatment of ocular disordersnon-living tissue grafts for surgical implantation
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/24/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/24/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/13/2024
IUAF
USE AMENDMENT FILED
05/09/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/15/2024
EX5G
SOU EXTENSION 5 GRANTED
02/14/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/13/2024
NREV
NOTICE OF REVIVAL - E-MAILED
12/28/2023
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
12/28/2023
PETG
PETITION TO REVIVE-GRANTED
12/28/2023
PROA
TEAS PETITION TO REVIVE RECEIVED
12/28/2023
EXT5
SOU EXTENSION 5 FILED
11/27/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2023
EX4G
SOU EXTENSION 4 GRANTED
03/28/2023
EXT4
SOU EXTENSION 4 FILED
03/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/24/2022
EX3G
SOU EXTENSION 3 GRANTED
09/22/2022
EXT3
SOU EXTENSION 3 FILED
09/22/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/30/2022
EX2G
SOU EXTENSION 2 GRANTED
03/28/2022
EXT2
SOU EXTENSION 2 FILED
03/28/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2021
EX1G
SOU EXTENSION 1 GRANTED
09/27/2021
EXT1
SOU EXTENSION 1 FILED
09/27/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/25/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/30/2021
PUBO
PUBLISHED FOR OPPOSITION
03/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2020
GNRT
NON-FINAL ACTION E-MAILED
10/05/2020
CNRT
NON-FINAL ACTION WRITTEN
10/05/2020
DOCK
ASSIGNED TO EXAMINER
10/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2020
NWAP
NEW APPLICATION ENTERED
07/03/2020
Continuous trademark protection
Get notified about every new filing that threatens OPSIS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.